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CASE REPORTCT demonstration of intravenous contrast medium
extravasation and subsequent resorption in the
mediastinum: a complication of a central venous
catheter injection
H. Wonga,*, S.K. Youngb, A. LincDepartments of aRadiology, Stanford University Medical Center, Stanford, bDiagnostic Imaging, and
cMedicine, Santa Clara Valley Medical Center, San Jose, California, USAIntroduction
Extravasation of iodinated contrast media into
peripheral soft tissue at the site of intravenous
(IV) injection is a familiar complication. Although
the reported overall rate of extravasation is
relatively low (0.04%–1.3%),1 it is commonly seen
because of the large number of radiological studies
that require the use of IV contrast media. In
particular, the increasing reliance on power injec-
tors that deliver contrast media at a fast rate for CT
studies has necessitated a high level of awareness
of the nature of extravasation, its prevention and
treatment.
Occasionally, an alternative route of contrast
administration may be required in patients with
poor peripheral IV access, and an existing central
venous catheter is used in some institutions
although this practice is discouraged by most
manufacturers of such catheters.2 Even though
the central line is carefully checked for patency
and integrity and the injection rate is typically
lowered, a theoretical risk exists for extravasation
along the course of the catheter and, specifically,
into the mediastinum. However, there is little
documentation in the literature of the natural
course of extravasated contrast media in the
mediastinum.
We present a case in which contrast medium was
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into an existing surgically implanted catheter and
was depicted on initial CT. Complete resorption of
contrast medium was demonstrated on follow-up
CT 24 h later.Case report
A 46-year-old woman with a history of stage IV
breast cancer underwent CT of the neck and chest
for restaging. Because of poor peripheral venous
access, injection was performed through an exist-
ing single-lumen central venous catheter (size 9.6
French). This surgically implanted device had been
used successfully for delivery of chemotherapy for 1
year. After the port was accessed in the left
anterior chest wall, and the patency of the line
was confirmed, approximately 100 ml Iohexol 240
(Amersham, Buckinghamshire) was administered
using a power injector (E-Z-EM) at a rate of
2 ml/s. The patient was not known to be allergic
to IV contrast media. During and after the contrast
administration, she reported no symptoms. CT (Fig.
1) demonstrated that there was no appreciable
contrast medium in blood vessels or any other
typically enhancing structures. Instead, it appeared
that the entire amount was deposited in the
mediastinum and anterior chest wall along the
line of the catheter. The woman continued to be
asymptomatic; specifically, she denied chest pain,
shortness of breath, wheezing, itching or rash. As a
precautionary measure, she was admitted to the
hospital for observation and underwent follow-up
chest CT without contrast (Fig. 2) 24 h after theClinical Radiology Extra (2005) 60, 13–15gists. Published by Elsevier Ltd. All rights reserved.
Figure 1 Axial CT at the level of the aortic arch
demonstrates contrast medium extravasation into the
mediastinum.
H. Wong et al.14initial study. CT demonstrated a normal mediasti-
num with complete interval resorption of the
extravasated contrast. The tip of the catheter was
at the wall of the distal left innominate vein, which
was the likely site of extravasation. The Mediport
was removed, and the woman did not experience
any adverse consequences during the ensuing 12Figure 2 Non-contrast axial CT at the level of the aortic
arch performed 24 h later demonstrates resolution of
mediastinal contrast medium extravasation.months. She ultimately died from complications
related to her breast cancer.Discussion
There is increasing use of CT, and advances in CT
technology continue to expand its application.
Furthermore, the standard use of power injectors
enables precise delivery of relatively high volumes
of contrast medium at relatively high rates (up to
5 ml/s now being routine). These factors justify the
increased attention now paid to the issue of IV
contrast medium extravasation in tissues.
Extravasation of iodinated contrast medium into
the soft tissues at the injection site in extremities
has been well studied. Extravasation is usually self-
limited, and in the majority (80%) of cases the
medium is resorbed within 24 h without sequelae.2
In addition to the commonly occurring local pain
and swelling, much rarer but more serious compli-
cations such as skin ulceration or necrosis and the
compartment syndrome are well known. Immediate
treatment of extravasation includes the customary
raising of the affected extremity and cold and hot
compresses, and the somewhat controversial use of
hyaluronidase. There has also been progress in
preventive measures, the most significant example
of which is the commercial introduction of an
extravasation detection accessory (EDA) a few
years ago. EDA, which can detect contrast medium
extravasation of as little as 15 ml, has been
successfully implemented in many centres.1,3
On the other hand, there has been little discus-
sion in the literature on the extravasation phenom-
enon in the mediastinum in the context of a CT
study. Early understanding of mediastinal extra-
vasation of iodinated contrast media focused on
orally administered water-soluble medium for
gastrointestinal studies. Typically the extravasa-
tion is in relatively small amounts and located
adjacent to the oesophagus. Relatively quick
resorption without serious sequelae is the norm.
For this reason, the use of water-soluble contrast
media is tolerated in a patient at risk for extra-
vasation from the oesophagus.
There were reports of mediastinal extravasation
of IV contrast medium during digital intravenous
angiography (DIVA), a popular alternative to arter-
iography, in the early 1980s. Because of the high
rate of the injection (up to 12 ml/s), the catheter
recoil presumably resulted in tissue damage, for
example in the superior vena cava or the right atrial
wall, and subsequent contrast medium extravasa-
tion into the mediastinum. Patients typically
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detected on fluoroscopy.4–8 In some cases follow-up
chest radiographs were performed, but in general
no adverse sequelae were reported.
Most manufacturers of central venous catheters
do not recommend the use of their products for the
purpose of contrast medium administration,
because of possible catheter damage, tissue injury
or medium extravasation. It is well known that a
small-bore catheter such as a PICC line easily
sustains damage when subjected to a medium to
high rate of injection by a power injector. However,
in many centres an existing catheter with a tip in a
central venous location is occasionally used for
contrast medium injection when there is poor
peripheral venous access.
According to reported cases of perforation of a
vessel wall by a central venous catheter and the
resultant inadvertent infusion of a chemotherapeu-
tic agent in the mediastinum,9–11 an acute severe
inflammatory reaction can occur with varied long-
term effects. It is plausible that water-soluble
contrast media, especially of the non-ionic variety,
may act in a more innocuous way than tissue-
vesicant medications.
To our knowledge, our case provides the first CT
documentation of the natural course of extrava-
sated IV contrast medium in the mediastinum. It
demonstrates that when a mediastinal vessel is
compromised, the volume of contrast medium
collects in the mediastinum as would be expected.
Although our patient remained asymptomatic,
possibly because of the much slower rate of
injection compared with the reported cases of
DIVA, we chose to observe her for 24 h and repeat
the CT because of the lack of data on the clinical
course of such patients.
This case illustrates that in a case of mediastinal
extravasation of a high volume of IV contrast
medium, complete resorption of the medium maybe expected and the patient is likely to remain
asymptomatic. However, it might be prudent to
document the initial extravasation on CT repeated
in 24 h as well as to observe the patient during this
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